The hPMSCs can mitigate the pathological damage in GVHD mouse model liver tissues by maintaining the balance in redox metabolism via enhancement of Nrf2 activation and attenuation of the activation of NF-κB in both tissues and mononuclear cells. The gene discussed is NFKB1; the disease is graft versus host disease.